On the other hand, studies have revealed substantially increased GDNF levels in PSP-P patients and less increased levels in PSP-RS patients; the authors suggest that in PSP, the GDNF levels in the serum initially rise as a protective mechanism [29]. Here, GDNF is linked to supranuclear palsy, progressive, 1.